piur imaging to sign the grant agreement for a EUR 2.1 m H2020 grant

Collaborating with four partners, piur imaging will develop the 2nd generation of PIUR tUS. This is a new device for tomographic 3D ultrasound allowing safe and more cost effective vascular diagnosis and treatment planning.

The H2020 Fast Track to Innovation Grant involves the following partners:

  • ACMIT GmbH
  • ImFusion GmbH
  • Independent Vascular Services Limited
  • The University of Manchester

The funding decision dates back to January 2017, the grant agreement has been signed on June 16, 2017.

About piur imaging
piur imaging´s mission is to make vascular imaging more affordable and safer for the patient through the innovative tomographic ultrasound solution PIUR tUS. PIUR tUS extends regular ultrasound devices with a tomography function so physicians can produce three-dimensional diagnostic information without the side effects current imaging technologies may introduce. Optimized usability and a high degree of automation improves diagnostic workflows and communication between physicians while eliminating the patient´s exposure to radiation and harmful contrast agents for several indications.

Press contact
Frederik Bender
Managing Director / CEO
Tel: +43 (0)12 650 16 1
Email: bender(at)piurimaging.com
Web: www.piurimaging.com

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.